This delayed gastric emptying means food takes longer to digest
Retatrutide is the first triple agonist (GLP-1, GIP, glucagon) to reach Phase 3 clinical trials for obesity
In type 1 diabetes, combination therapies have primarily focused on glucose control and safety, with several randomized controlled trials investigating the effects of combining treatments such as SGLT2is and GLP-1RAs with insulin
For research into skin improvement, anti-aging, collagen, skin repair and hair growth, via the copper binding and the influence on the extracellular matrix
That said, sermorelin also supports metabolic health through improved GH levels, better sleep, and enhanced body composition, making it a reasonable long-term option for individuals without significant visceral fat concerns